C1 esterase inhibitor (Boya Bio-Pharmaceutical)

C1酯酶抑制剂（华润博雅生物制药）

Report date: 2023/12/05 20:06:40

Base Information

Drug NameC1 esterase inhibitor (Boya Bio-Pharmaceutical)
Drug Alias NameC1 esterase inhibitorC1酯酶抑制剂C1-INH补充C1抑制蛋白
ClassificationBiologics > Blood components
Mechanisms of ActionSerine protease inhibitorsComplement C1s inhibitorsComplement C1r inhibitors
TargetsSerine proteaseComplement C1sComplement C1r
Therapy Area/IndicationsAngioedemas, Hereditary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesBoya Bio-Pharmaceutical Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBoya Bio-Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsAngioedemas, Hereditary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A